We are live on ! Find out more
DBIA

Dumont & Blake Investment Advisors Portfolio holdings

AUM $445M
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+31.98%
3 Year Est. Return
+78.27%
5 Year Est. Return
+88.91%
10 Year Est. Return
+293.66%
AUM
$210M
AUM Growth
+$43.8M
Cap. Flow
+$35.2M
Cap. Flow %
16.73%
Top 10 Hldgs %
25.89%
Holding
158
New
24
Increased
45
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
DVY icon
iShares Select Dividend ETF
DVY
+$7.22M
2
CHY
Calamos Convertible and High Income Fund
CHY
+$2.93M
3
AMLP icon
Alerian MLP ETF
AMLP
+$2.92M
4
VYM icon
Vanguard High Dividend Yield ETF
VYM
+$2.45M
5
PCEF icon
Invesco CEF Income Composite ETF
PCEF
+$2.31M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$983K
2
AFL icon
Aflac
AFL
+$448K
3
TKR icon
Timken Company
TKR
+$423K
4
F icon
Ford
F
+$42.2K
5
BAC icon
Bank of America
BAC
+$37.1K

Sector Composition

Rank Sector Weight
1 Technology 10.21%
2 Financials 10.18%
3 Healthcare 8.63%
4 Industrials 7.14%
5 Energy 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ED icon
126
Consolidated Edison
ED
$39.9B
$247K 0.12%
4,471
+350
+8% +$20.2K
F icon
127
Ford
F
$55.7B
$245K 0.12%
14,540
-2,500
-15% -$42.2K
GIS icon
128
General Mills
GIS
$19.7B
$235K 0.11%
4,900
-200
-4% -$10K
SGEN
129
DELISTED
Seagen Inc. Common Stock
SGEN
$219K 0.1%
+5,000
New +$208K
TIF
130
DELISTED
Tiffany & Co.
TIF
$207K 0.1%
+2,700
New +$213K
MCD icon
131
McDonald's
MCD
$195B
$201K 0.1%
2,090
– –
RXII
132
DELISTED
GALENA BIOPHARMA INC COM
RXII
$57K 0.03%
25,100
+6,500
+35% +$14.8K
DCTH
133
DELISTED
Delcath Systems Inc
DCTH
$23K 0.01%
272
– –
BRD
134
DELISTED
BRIGUS GOLD CORP COM STK
BRD
$21K 0.01%
35,000
+10,000
+40% +$5.52K
GSS
135
DELISTED
Golden Star Resources Ltd.
GSS
$16K 0.01%
8,200
+4,000
+95% +$10.5K
XRA
136
DELISTED
Exeter Resources Corporation
XRA
$8K ﹤0.01%
10,000
– –
VGZ icon
137
Vista Gold
VGZ
$308M
$7K ﹤0.01%
15,000
– –
JAG
138
DELISTED
JAGUAR MINING INC
JAG
$6K ﹤0.01%
30,000
– –
RGN
139
DELISTED
REGENERX BIOPHARMACEUTICALS
RGN
$4K ﹤0.01%
62,537
– –
GORX
140
DELISTED
GEOPHARMA INC
GORX
$1K ﹤0.01%
40,000
– –
XBI icon
141
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-28,290
Closed -$983K
2 3 4 5
6

Similar funds

BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.14% 1-Year Est. Return
RWM
Rialto Wealth Management Syracuse, New York $445M AUM 15.58% 1-Year Est. Return
AFA
Abacus FCF Advisors Orlando, Florida $444M AUM 44.44% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
WCP
Welch Capital Partners Harrison, New York $444M AUM 21.45% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
TC
TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return
CMP
Coston McIsaac & Partners Bar Harbor, Maine $443M AUM 6.68% 1-Year Est. Return

Dumont & Blake Investment Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Dumont & Blake Investment Advisors held 158 positions worth $210M, up 26% from $167M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dumont & Blake Investment Advisors deployed $35.2M of net new capital in Q3 2013, opening 24 new positions and adding to 45 existing holdings. Its largest new stake was iShares Select Dividend ETF: 108,584 shares worth $7.2M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Aflac, an estimated $448K trimmed.

  • Dumont & Blake Investment Advisors's largest Q3 2013 buy was iShares Select Dividend ETF: 108,584 shares worth $7.2M.
  • Dumont & Blake Investment Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2013, an estimated $253K increase.
  • Dumont & Blake Investment Advisors's biggest Q3 2013 reduction was Aflac, cutting an estimated $448K.
  • Dumont & Blake Investment Advisors fully exited State Street SPDR S&P Biotech ETF in Q3 2013, selling an estimated $983K.
  • Dumont & Blake Investment Advisors's ten largest holdings make up 26% of its $210M portfolio in Q3 2013.
  • Dumont & Blake Investment Advisors opened 24 new positions and closed 7 in Q3 2013.
  • Dumont & Blake Investment Advisors's portfolio value rose 26% quarter-over-quarter to $210M.

Based on Dumont & Blake Investment Advisors's 13F filing for Q3 2013, filed 5 Nov 2013.